Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis

Journal of Clinical Investigation

Volumn 110, Issue 12, 2002, Pages 1859-1868

  Nishida, Masashi ^a   Fujinaka, Hidehiko ^a   Matsusaka, Taiji ^a,b   Price, James ^a   Kon, Valentina ^a   Fogo, Agnes B ^a   Davidson, Jeffrey M ^a   Linton, MacRae F ^a   Fagio, Sergio ^a   Homma, Toshio ^b   Yoshida, Hiroaki ^a   Ichikawa, Iekuni ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CANCER GROWTH FACTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; BONE MARROW; CELL FUNCTION; CONTROLLED STUDY; EVOLUTION; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL; URETER OBSTRUCTION; URINARY TRACT OBSTRUCTION; WILD TYPE;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; COLLAGEN TYPE I; COLLAGEN TYPE III; EXTRACELLULAR MATRIX; FIBROSIS; HEMATOPOIETIC STEM CELLS; KIDNEY; KIDNEY DISEASES; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RESPIRATORY BURST; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 0036950667     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200215045     Document Type: Article

References (44)

1. Anderson, S., Meyer, T.W., Rennke, H.G., and Brenner, B.M. 1985. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 76:612-619.
2. Lewis, E.J., Hunsicker, L.G., Bain, R.P., and Rohde, R.D. 1993. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329:1456-1462.
3. Marre, M., et al. 1997. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J. Clin. Invest. 99:1585-1595.
4. Holdsworth, S.R., Neale, T.J., and Wilson, C.B. 1981. Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J. Clin. Invest. 68:686-698.
5. Van Goor, H., van der Horst, M.L., Fidler, V., and Grond, J. 1992. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab. Invest. 66:564-571.
6. Schreiner, G.F., Harris, K.P., Purkerson, M.L., and Klahr, S. 1988. Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int. 34:487-493.
7. Van Goor, H., et al. 1994. Macrophages and renal disease. Lab. Invest. 71:456-464.
8. Schreiner, G.F. 1991. The role of the macrophage in glomerular injury. Semin. Nephrol. 11:268-275.
9. Klahr, S., Ishidoya, S., and Morrissey, J. 1995. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am. J. Kidney Dis. 26:141-146.
10. Ishidoya, S., Morrissey, J., McCracken, R., Reyes, A., and Klahr, S. 1995. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int. 47:1285-1294.
11. Diamond, J.R., and Pesek-Diamond, I. 1991. Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: Role of macrophages. Am. J. Physiol. 260:F779-F786.
12. Leibovich, S.J., and Ross, R. 1975. The role of the macrophage in wound repair: A study with hydrocortisone and antimacrophage serum. Am. J. Pathol. 78:71-100.
13. Singer, A.J., and Clark, R.A. 1999. Cutaneous wound healing. N. Engl. J. Med. 341:738-746.
14. Danon, D., Kowatch, M.A. and Rorh, G.S. 1989. Promotion of wound repair in old mice by local injection of macrophages. Proc. Natl. Acad. Sci. USA. 86:2018-2020.
15. DiPietro, L.A., Burdick, M., Low, O.E., Kunkel, S.L., and Stricter, R.M. 1998. MIP-1a as a critical macrophage chemoattractant in murine wound repair. J. Clin. Invest. 101:1693-1698.
16. Foris, G., Dezso, B., Medgyesi, G.A., and Fust, G. 1983. Effect of angiotensin II on macrophage functions. Immunology. 48:529-535.
17. Okamura, A., et al. 1999. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J. Hypertens. 17:537-545.
18. Yanagitani, Y., et al. 1999. Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension. 33:335-339.
19. Lijnen, P., Fagard, R., and Petrov, V. 1997. Cytosolic calcium changes induced by angiotensin II in human peripheral blood mononuclear cells are mediated via angiotensin II subtype 1 receptors. J. Hypertens. 15:871-876.
20. Nataraj, C., et al. 1999. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J. Clin. Invest. 104:1693-1701.
21. Rodgers, K.E., Xiong, S., Steer, R., and diZerega, G.S. 2000. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Calls. 18:287-294.
22. Linton, M.F., Atkinson, J.B., and Fazio, S. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267:1034-1037.
23. Yoshida, H., et al. 2001. Isoform-specific effects of apolipoprotein E on atherogenesis: Gene transduction studies in mice. Circulation Res. 104:2820-2825.
24. Matsusaka, T., et al. 1996. Chimeric mice carrying "regional" targeted deletion of the angiotensin type 1A receptor gene. Evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J. Clin. Invest. 98:1867-1877.
25. Yoshida, H., et al. 1992. Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem. Biophys. Res. Commun. 186:1042-1049.
26. Chen, X., et al. 1997. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am. J. Physiol. 272:F299-F304.
27. Ma, J., et al. 1998. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int. 53:937-944.
28. Miyazaki, Y., Tsuchida, S., Fogo, A., and Ichikawa, I. 1999. The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney Int. 55:1683-1695.
29. DeLisser, H.M., Newman, P.J., and Albelda, S.M. 1994. Molecular and functional aspects of PECAM-1/CD31. Immunol. Today. 15:490-495.
30. Kang, D.H., et al. 2001. Impaired angiogenesis in the remnant kidney model: I. Potenrial role of vascular endothelial growth factor and thrombospondin-1. J. Am. Soc. Nephrol. 12:1434-1447.
31. Ma, L.J., et al. 2000. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int. 58:2425-2436.
32. Lieschke, G.L., et al. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyore and macrophage progenitor cell deficiency, and impaired neutrophil mobilizarion. Blood. 84:1737-1746.
33. Scott, R.S., et al. 2001. Phagocyrosis and clearance of apoptotic cells is mediated by MER. Nature. 411:207-211.
34. Djaldetti, M., et al. 1997. A simple method for evaluation of latex phagocytosis by rat peritoneal macrophages. Acta Haematol. 98:56-57.
35. Yokota, T., et al. 2000. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 96:1723-1732.
36. Ohashi, R., Shimizu, A., Masuda, Y., Ishizuka, M., and Yamanaka, N. 2000. Angiogenesis and subsequent regression of peritubular capillary (PTC) in the unilateral ureteral obstruction (UUO) model. J. Am. Soc. Nephrol. 11:514A. (Abstr.)
37. Yang, J., and Liu, Y. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159:1465-1475.
38. Diamond, J.R., Kees-Folts, D., Ding, G., Frye, J.E., and Restrepo, N.C. 1994. Macrophages, monocyte chemoattractant peptide-1, and TGF-β1 in experimental hydronephrosis. Am. J. Physiol. 266:F926-F933.
39. Kintsher, U., et al. 2001. Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes. Hypertension. 37:587-593.
40. Ricardo, S.D., and Diamond, J.R. 1998 The role of macrophages and reactive oxygen species in experimental hydronephrosis. Sem. Nephrol. 18:612-621.
41. Hayek, T., Aviram, M., Heinrich, R., Sakhnini, E., and Keidar, S. 2000. Losartan inhibits cellular uptake of oxidized LDL by monocytemacrophages from hypercholesterolemic patients. Biochem. Biophys. Res. Commun. 273:417-420.
42. Moxey-Mims, M.M., and Noble, B. 1994. Glomerular macrophage phagocytic activity in experimental immune complex nephritis. Kidney Int. 45:1326-1332.
43. Satoh, M., et al. 2001. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J. Am. Soc. Nephrol. 12:317-325.
44. Thomas, S.E., et al. 1998. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int. 53:897-908.